Erratum to: The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries (Adv Ther, 10.1007/s12325-017-0522-y)

TY - JOUR

T1 - Erratum to: The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries (Adv Ther, 10.1007/s12325-017-0522-y)

AU - Gulácsi, L.

AU - Brodszky, V.

AU - Baji, P.

AU - Rencz, F.

AU - Péntek, M.

PY - 2017

Y1 - 2017

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-85018366112&partnerID=MN8TOARS

U2 - 10.1007/s12325-017-0538-3

DO - 10.1007/s12325-017-0538-3

M3 - Article (Academic Journal)

C2 - 28447267

SN - 0741-238X

JO - Advances in Therapy

JF - Advances in Therapy

ER -